Characteristics and Outcomes of Concurrently Diagnosed New Rapid Atrial Fibrillation or Flutter and New Reduced Ejection Fraction

• Published in: Pacing and clinical electrophysiology Vol. 39; no. 12; pp. 1394 - 1403
• Main Authors: RODRIGUEZ, YASSER, ALTHOUSE, ANDREW D., ADELSTEIN, EVAN C., JAIN, SANDEEP K., MENDENHALL, GEORGE STUART, SABA, SAMIR, SHALABY, ALAA A., VOIGT, ANDREW H., WANG, NORMAN C.
• Format: Journal Article
• Language: English
• Published: United States Blackwell Publishing Ltd 01.12.2016
• Subjects: Alcoholism - mortality; atrial fibrillation; Atrial Fibrillation - mortality; Atrial Fibrillation - prevention & control; atrial flutter; Atrial Flutter - mortality; Atrial Flutter - prevention & control; Causality; Cohort Studies; Comorbidity; Disease-Free Survival; Early Diagnosis; Electric Countershock - mortality; Electric Countershock - utilization; Female; heart failure; Humans; left atrial appendage thrombi; Male; Middle Aged; Pennsylvania - epidemiology; Prevalence; Prognosis; Retrospective Studies; Risk Factors; Stroke Volume; Survival Rate; transesophageal echocardiography; Treatment Outcome; Ventricular Dysfunction, Left - mortality; Ventricular Dysfunction, Left - prevention & control; heart failure; atrial fibrillation; left atrial appendage thrombi; transesophageal echocardiography; atrial flutter
• ISSN: 0147-8389; 1540-8159
• DOI: 10.1111/pace.12981

Background Characteristics and outcomes of concurrently diagnosed new rapid atrial fibrillation (AF) or atrial flutter (AFL) and new heart failure with reduced left ventricular ejection fraction (LVEF) are not well described. Methods A retrospective cohort study of subjects referred for expedited transesophageal echocardiography‐guided rhythm‐control strategies for concurrent new rapid AF/AFL and new LVEF ≤ 40% diagnosed during the same admission was analyzed. Results Twenty‐five subjects (median age 57 years; 96% male; 96% Caucasian; median CHA2DS2‐VASc = 2) presented with new AF (n = 18) or AFL (n = 7) with rapid ventricular rate (median 135 beats/min) and new reduced LVEF (median 27%; range, 10–37.5%). Seven (28%) subjects had left atrial appendage thrombi (LAAT) and five (20%) subjects had heavy or binge alcohol use. Baseline characteristics were similar between those with and without LAAT. Thirteen subjects with AF and without LAAT underwent direct‐current cardioversion (DCCV) and 10 (77%) had AF recurrence within 90 days. Improvement of long‐term LVEF to >40% was comparable for subjects with and without initial LAAT (83% vs 94%; P = 0.46). Three of four subjects who received primary prophylaxis implantable cardioverter‐defibrillators improved their LVEF to >35% after sinus rhythm maintenance. The median long‐term follow‐up time was 3.0 years. Conclusions Subjects with concurrently diagnosed new rapid AF/AFL and new reduced LVEF are characterized by a high prevalence of LAAT and significant alcohol use. AF subjects without initial LAAT who underwent DCCV had a high 90‐day AF recurrence rate. The presence of LAAT did not have a prognosticative effect on eventual LVEF improvement, which was observed in almost all subjects.